Characterization of CPH:SA microparticle‐based delivery of interleukin‐1 alpha for cancer immunotherapy
Abstract Background Interleukin‐1 alpha (IL‐1α) is a pro‐inflammatory cytokine that can activate immune effector cells and trigger anti‐tumor immune responses. However, dose‐limiting toxicities including cytokine storm and hypotension has limited its use in the clinic as a cancer therapy. We propose...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2023-05-01
|
| Series: | Bioengineering & Translational Medicine |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/btm2.10465 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|